Immunoassay Market by Product & Data Validation, Analysis and Forecast 2022
According to Publisher, the global immunoassay market is estimated at $16.35 billion in 2015 and is expected to grow at a CAGR of 10.9% to reach $33.72 billion by 2022. Technological advancements and increasing geriatric population worldwide are some of the key factors fuelling the market growth. Increasing incidences of infectious & chronic diseases, demand for non-invasive diagnostic techniques, broad usage of immunoassays in oncology, growing need of reagents and speed, cost effectiveness & accuracy of immunoassay are additional drivers playing a key role in the growth of immunoassay market. However, execution of excise duty by the U.S. government and low detection limit are the factors limiting the market growth. Expansion of pharmaceutical and biotechnology industries in emerging regions such as Asia Pacific acts as opportunity for immunoassay market.
For more information http://www.reportsweb.com/immunoassay-global-market-outlook-2015-2022
In 2015, Enzyme-Linked Immunosorbent Assay (ELISA) and Enzyme-linked ImmunoSpot (ELISPOT) assay dominated the global immunoassay technology market due to their high sensitivity and long term presence in the market. Oncology segment is witnessing a significant growth driven by the high incidence of cancer diseases. North America is anticipated to be the largest market for immunoassay, whereas Asia Pacific and MEA are projected to grow at a faster pace. The aging US population is supporting the market demand, since the requirement of these medical devices is higher in the elderly population.
The technological advancements, rising investments in pharmaceutical and biotechnology sector by government and corporate sector and rapidly growing healthcare market in emerging countries such as China and India are the factors favouring the market growth in this region.
Some of the key players in the global immunoassay market include Roche Diagnostics Limited, Thermo Fisher Scientific, Inc, Danaher Corporation, Siemens Healthcare, Becton, Dickinson And Company, Abbott Laboratories, Inc, Luminex Corporation, Bio-Rad Laboratories, Inc., Sysmex Corporation, Biomérieux SA, Ortho-Clinical Diagnostics, Inc., Alere, Inc., Qiagen NV, Meridian Life Science, Inc and Syntron Bioresearch, Inc.
Products & Services Covered:
-Software and Services
-Analyzers
-Purchase Modes Analysers
-Analyser Type
-Reagents & KITS
-Radioimmunoassay (RIA)
-Western Blot
-Polymerase Chain Reaction (PCR)
-Enzyme-Linked Immunospot (ELISPOT)
-Rapid Tests
-Enzyme-Linked Immunosorbent Assay (ELISA) Reagents
Technologies Covered:
-Radio Immunoassays (RIA)
-Nephelometric Immunoassay
-Western Blot
-Fluorescence Immunoassay
-Enzyme-Linked Immunosorbent Assay (ELISA)
-Rapid Tests
-Polymerase Chain Reaction (PCR)
-Chemiluminescence Immunoassay
-Enzyme-linked ImmunoSpot (ELISPOT) Assay
End Users Covered:
-Pharma & Biotech Firms
-Blood Banks
-Hospitals
-Clinical Laboratories
-Academic Research Centers
-Contract Research Organizations
-Other End Users
Applications Covered:
-Cardiology
-Autoimmune Disorders
-Oncology
-Toxicology
-Infectious Diseases
-Neonatal Screening
-Hematology and Blood Screening
-Endocrinology
-Bone and Mineral Disorders
-Other Applications
Request Sample Copy http://www.reportsweb.com/inquiry&RW0001322740/sample
Regions Covered:
-North America
-US
-Canada
-Mexico
-Europe
-Germany
-France
-Italy
-UK
-Spain
-Rest of Europe
-Asia Pacific
-Japan
-China
-India
-Australia
-New Zealand
-Rest of Asia Pacific
-Rest of the World
-Middle East
-Brazil
-Argentina
-South Africa
-Egypt
11 Company Profiling
11.1 Roche Diagnostics Limited
11.2 Thermo Fisher Scientific, Inc
11.3 Danaher Corporation
11.4 Siemens Healthcare
11.5 Becton, Dickinson And Company
11.6 Abbott Laboratories, Inc
11.7 Luminex Corporation
11.8 Bio-Rad Laboratories, Inc.
11.9 Sysmex Corporation
11.10 Biomérieux SA
11.11 Ortho-Clinical Diagnostics, Inc.
11.12 Alere, Inc.
11.13 Qiagen NV
11.14 Meridian Life Science, Inc
11.15 Syntron Bioresearch, Inc.
Make an enquiry: http://www.reportsweb.com/inquiry&RW0001322740/buying
Contact Us:
Call: +1-646-491-9876
Email: [email protected]
